Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.

Abstract

Authors

• Shuxiao Ma
  Henan Key Laboratory of Imaging and Intelligent Processing, PLA Strategic Support Force Information Engineering University, Zhengzhou, 450000, China.
• Lu Zhou
  School of Environment, Tsinghua University Beijing 100084 P. R. China zhoulu@mail.tsinghua.edu.cn.
• Yi Liu
  Department of Interventional Therapy, Ningbo No. 2 Hospital, Ningbo, China.
• Hui Jie
  Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
• Min Yi
  Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
• Chenglin Guo
  Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
• Jiandong Mei
  Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
• Chuan Li
  State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
• Lei Zhu
  School of Civil and Hydraulic Engineering, Ningxia University, Yinchuan, China.
• Senyi Deng
  Institute of Thoracic Oncology, Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610065, China. senyi_deng@scu.edu.cn.

Keywords

External Resources